HMOX1 and metabolic dysfunction-associated steatotic liver disease: It is also found that the administration of EET leads to reduced fatty acid accumulation and improves the status of NAFLD in db/db mice (60), while inhibition of the antioxidant activity of HO exacerbates hepatic steatosis and fibrosis in hepatic cells (61).